IBDEI164 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20919,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20919,1,4,0)
 ;;=4^420.91
 ;;^UTILITY(U,$J,358.3,20919,1,5,0)
 ;;=5^Pericarditis, Acute Idiopathic
 ;;^UTILITY(U,$J,358.3,20919,2)
 ;;=   ^269695
 ;;^UTILITY(U,$J,358.3,20920,0)
 ;;=780.2^^133^1307^75
 ;;^UTILITY(U,$J,358.3,20920,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20920,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,20920,1,5,0)
 ;;=5^Syncope
 ;;^UTILITY(U,$J,358.3,20920,2)
 ;;=Syncope^116707
 ;;^UTILITY(U,$J,358.3,20921,0)
 ;;=443.9^^133^1307^63
 ;;^UTILITY(U,$J,358.3,20921,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20921,1,4,0)
 ;;=4^443.9
 ;;^UTILITY(U,$J,358.3,20921,1,5,0)
 ;;=5^PVD
 ;;^UTILITY(U,$J,358.3,20921,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,20922,0)
 ;;=440.21^^133^1307^65
 ;;^UTILITY(U,$J,358.3,20922,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20922,1,4,0)
 ;;=4^440.21
 ;;^UTILITY(U,$J,358.3,20922,1,5,0)
 ;;=5^PVD w/ Intermittent Claudication
 ;;^UTILITY(U,$J,358.3,20922,2)
 ;;=^293885
 ;;^UTILITY(U,$J,358.3,20923,0)
 ;;=440.23^^133^1307^66
 ;;^UTILITY(U,$J,358.3,20923,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20923,1,4,0)
 ;;=4^440.23
 ;;^UTILITY(U,$J,358.3,20923,1,5,0)
 ;;=5^PVD w/ Ulceration
 ;;^UTILITY(U,$J,358.3,20923,2)
 ;;=^295739
 ;;^UTILITY(U,$J,358.3,20924,0)
 ;;=440.24^^133^1307^64
 ;;^UTILITY(U,$J,358.3,20924,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20924,1,4,0)
 ;;=4^440.24
 ;;^UTILITY(U,$J,358.3,20924,1,5,0)
 ;;=5^PVD w/ Gangrene
 ;;^UTILITY(U,$J,358.3,20924,2)
 ;;=PVD w/ Gangrene^295740
 ;;^UTILITY(U,$J,358.3,20925,0)
 ;;=V45.81^^133^1307^71
 ;;^UTILITY(U,$J,358.3,20925,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20925,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,20925,1,5,0)
 ;;=5^S/P CABG
 ;;^UTILITY(U,$J,358.3,20925,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,20926,0)
 ;;=459.81^^133^1307^81
 ;;^UTILITY(U,$J,358.3,20926,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20926,1,4,0)
 ;;=4^459.81
 ;;^UTILITY(U,$J,358.3,20926,1,5,0)
 ;;=5^Venous Insufficiency
 ;;^UTILITY(U,$J,358.3,20926,2)
 ;;=^125826
 ;;^UTILITY(U,$J,358.3,20927,0)
 ;;=V45.01^^133^1307^73
 ;;^UTILITY(U,$J,358.3,20927,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20927,1,4,0)
 ;;=4^V45.01
 ;;^UTILITY(U,$J,358.3,20927,1,5,0)
 ;;=5^S/P Pacer Placement
 ;;^UTILITY(U,$J,358.3,20927,2)
 ;;=^303419
 ;;^UTILITY(U,$J,358.3,20928,0)
 ;;=427.31^^133^1307^12
 ;;^UTILITY(U,$J,358.3,20928,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20928,1,4,0)
 ;;=4^427.31
 ;;^UTILITY(U,$J,358.3,20928,1,5,0)
 ;;=5^Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,20928,2)
 ;;=^11378
 ;;^UTILITY(U,$J,358.3,20929,0)
 ;;=427.89^^133^1307^13
 ;;^UTILITY(U,$J,358.3,20929,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20929,1,4,0)
 ;;=4^427.89
 ;;^UTILITY(U,$J,358.3,20929,1,5,0)
 ;;=5^Bradycardia
 ;;^UTILITY(U,$J,358.3,20929,2)
 ;;=Bradycardia^87896
 ;;^UTILITY(U,$J,358.3,20930,0)
 ;;=427.9^^133^1307^19
 ;;^UTILITY(U,$J,358.3,20930,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20930,1,4,0)
 ;;=4^427.9
 ;;^UTILITY(U,$J,358.3,20930,1,5,0)
 ;;=5^Cardiac Dysrythmia
 ;;^UTILITY(U,$J,358.3,20930,2)
 ;;=^10166
 ;;^UTILITY(U,$J,358.3,20931,0)
 ;;=427.0^^133^1307^68
 ;;^UTILITY(U,$J,358.3,20931,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20931,1,4,0)
 ;;=4^427.0
 ;;^UTILITY(U,$J,358.3,20931,1,5,0)
 ;;=5^Paroxysmal Supravent Tachycardia
 ;;^UTILITY(U,$J,358.3,20931,2)
 ;;=^90479
 ;;^UTILITY(U,$J,358.3,20932,0)
 ;;=427.81^^133^1307^74
 ;;^UTILITY(U,$J,358.3,20932,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20932,1,4,0)
 ;;=4^427.81
 ;;^UTILITY(U,$J,358.3,20932,1,5,0)
 ;;=5^Sick Sinus Syndrome
